Alpha Cognition (ACOG) EBIT Margin (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly EBIT Margin of 283.75% for Q4 2025, down 51.75% quarter-over-quarter from 186.99% in Q3 2025.

Alpha Cognition (ACOG) EBIT Margin (2025 - 2026) Analysis & Trends

Alpha Cognition's EBIT Margin history runs 1 years deep, the most recent figure standing at 283.75% for Q4 2025.

In Q4 2025, EBIT Margin changed N/A year-over-year to 283.75%; the TTM figure through Dec 2025 stood at 221.72% (changed N/A YoY), while the FY2025 annual figure was 221.72%, changed N/A from the prior year.
EBIT Margin for Q4 2025 stood at 283.75%, down from 186.99% in the prior quarter.
The five-year high for EBIT Margin was 125.87% in Q1 2025, with the low at 346.08% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	Vertex Pharmaceuticals	138.53 Bn	130.68 Bn	2.84 Bn	37.40%
2	Regeneron Pharmaceuticals	86.34 Bn	78.35 Bn	3.93 Bn	30.15%
3	Argenx Se	64.67 Bn	59.48 Bn	1.37 Bn	32.54%
4	Moderna	59.04 Bn	53.90 Bn	52.00 Mn	-562.07%
5	BeOne Medicines	42.03 Bn	36.94 Bn	1.53 Bn	19.06%
6	Alnylam Pharmaceuticals	30.78 Bn	27.47 Bn	992.69 Mn	17.93%
7	BioNTech SE	27.81 Bn	9.42 Bn	668.28 Mn	-35.57%
8	Insmed	27.21 Bn	26.05 Bn	358.27 Mn	-0.36%
9	Royalty Pharma	26.99 Bn	26.15 Bn	-	19.75%
10	Alpha Cognition	219.37 Mn	177.93 Mn	5.70 Mn	-127.29%

Download Data